Antierythropoietin antibodies in thalassemia patients

Annals of Hematology

Volumn 83, Issue 1, 2004, Pages 22-27

  Voulgari, P V ^a   Chaidos, A ^a   Tzouvara, E ^a   Alymara, V ^a   Alamanos, Y ^b   Drosos, A A ^a   Bourantas, K L ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Antierythropoietin antibodies; Antinuclear antibodies; Autoantibodies; Recombinant human erythropoietin; Thalassemia patients

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; ERYTHROPOIETIN; HEMOGLOBIN; HORMONE ANTIBODY; HYDROXYUREA; RECOMBINANT ERYTHROPOIETIN; RHEUMATOID FACTOR;

ADULT; ANTIBODY DETECTION; ARTICLE; BLOOD ANALYSIS; BLOOD CELL COUNT; CONTROLLED STUDY; DRUG RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE TRANSFUSION; FEMALE; HEMOGLOBIN DETERMINATION; HORMONE BLOOD LEVEL; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SICKLE CELL; STATISTICAL SIGNIFICANCE; THALASSEMIA; THALASSEMIA MAJOR;

ADOLESCENT; ADULT; AUTOANTIBODIES; BLOOD CELL COUNT; BLOOD TRANSFUSION; ERYTHROPOIETIN; FEMALE; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; THALASSEMIA;

EID: 0346007925     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-003-0777-z     Document Type: Article

References (42)

1. Agarwal MB, Viswanathan C, Gupte SS, Desai NG, Yasandani D, Bhave AA (1992) Anti-nuclear antibody positivity in multi-transfused thalassemia major. Indian Pediatr 29:607-610
2. Al-Khatti A, Veith RW, Papayannopoulou T, Fritsch EF, Goldwasser E, Stamatoyannopoulos G (1987) Stimulation of fetal hemoglobin synthesis by erythropoietin in baboons. N Engl J Med 317:415-420
3. Barany P (2001) Inflammation serum C-reactive protein, and erythropoietin resistance. Nephrol Dial Transpant 16:224-227
4. Bendtzen K, Hansen MB, Ross CHR, Svenson M (1996) Cytokine autoantibodies. In: Peter J, Shoenfeld Y (eds) Autoantibodies. Elsevier Science, Amsterdam
5. Bourantas K, Economou G, Georgiou J (1997) Administration of high doses of recombinant human erythropoietin to patients with beta-thalassemia intermedia: a preliminary trial. Eur J Haematol 58:22-25
6. Bourantas KL, Georgiou I, Seferiadis K (1994) Fetal globin stimulation during a short-term trial of erythropoietin in HbS/beta-thalassemia patients. Acta Haematol 92:79-82
7. Bourantas KL, Makrydimas G, Georgiou J, Tsiara S, Lolis D (1996) Preliminary results with administration of recombinant human erythropoietin in sickle cell/beta-thalassemia patients during pregnancy. Eur J Haematol 56:326-328
8. Bunn HF (2000) Drug-induced autoimmume red cell aplasia. N Engl J Med 346:522-523
9. Casadevall N, Dupuy E, Molho-Sabatier P, Tobelem G, Varet B, Mayeux P (1996) Autoantibodies against erythropoietin in a patient with pure red-cell aplasia. N Engl J Med 334:630-633
10. Casadevall N, Nataf J, Virou B, Kolta A, Kiladjian JJ, Martin-Dupout P, Michaud P, Papo T, Ugo V, Teyssandier I, Varet B, Mayeuy P (2002) Pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. N Engl J Med 346:467-475
11. Castelli G, Famularo A, Semico C, Machi A, Ceci A, Cannella G, Melioli G (2000) Detection of anti-erythropoietin antibodies in haemodialysis patients treated with recombinant human-erythropoietin. Pharmacol Res 41:313-318
12. Castellino SM, Combs MR, Zimmerman SA, Issitt PD, Ware RE (1999) Erythrocyte autoantibodies in paediatric patients with sickle cell disease receiving transfusion therapy: frequency, characteristics and significance. Br J Haematol 104:189-194
13. Chaisiripoomkere W, Jootar S, Chanjarunee S, Ungkanont A (1999) Serum erythropoietin levels in thalassemia major and intermedia. Southeast Asian J Trop Med Public Health 30:786-788
14. Chen JS, Lin KH, Wang ST, Tsao CJ, Yeh TF (1998) Blunted serum erythropoietin response to anemia in patients polytranfused for beta-thalassemia major. J Pediatr Hematol Oncol 20:140-144
15. Economidou J, Pathouli C, Hatziyannis S, Fostiropoulos G, Constantoulakis M (1976) Complement levels in relation to certain antibodies in polytransfused thalassemic patients. Vox Sang 31 [Suppl 1]:32-38
16. Galanello R, Stamatoyannopoulos G, Papayannopoulou T (1988) Mechanism of Hb F stimulation by S-stage compounds. In vitro studies with bone marrow cells exposed to 5-azacytidine, Ara-C or hydroxyurea. J Clin Invest 81:1209-1216
17. Goicoechea M, Martin J, de Sequera P, Quiroga JA, Ortiz A, Carreno V, Caramelo C (1998) Role of cytokines in the response to erythropoietin in hemodialysis patients. Kidney Int 54:1337-1343
18. Maeda Y, Sakaguchi M, Naiki Y, Sumimoto Y, Miyatake JI, Matsuda M, Hasegawa H, Kanamaru A (2001) Possible involvement of soluble erythropoietin receptor in resistance to erythropoietin in patients with renal anemia. Am J Nephrol 21:426
19. Makis AC, Chaliasos N, Hatzimichael EC, Bourantas KL (2001) Recombinant human erythropoietin therapy in a transfusion-dependent beta-thalassemia major patient. Ann Haematol 80:492-495
20. Mehta J, Chablani A, Reporter R, Singhal S, Mehta BC (1993) Autoantibodies in thalassemia major: relationship with chelator L1. J Assoc Physicians India 41:339-341
21. Mohn JF, Lambert RM, Bowman HS, Brason FW (1997) Experimental production in man of autoantibodies with Rh specificity. Ann N Y Acad Sci 124:477-483
22. Nisli G, Kavakli K, Aydinok Y, Oztop S, Cetingul N, Basak N (1997) Recombinant erythropoietin trial in children with transfusion-dependent homozygous beta-thalassemia. Acta Haematol 98:199-203
23. Leroy-Viard K, Rouyer-Fessard P, Beuzard Y (1991) Improvement of mouse beta thalassemia by recombinant human erythropoietin. Blood 78:1596-1602
24. Letvin NL, Linch DC, Beardsley P, McIntyre KW, Nathan DG (1984) Augmentation of fetal-hemoglobin production in anemic monkeys by hydroxyurea. N Engl J Med 310:869-873
25. Li Q, Emery DW, Fernandez M, Han H, Stamatoyannopoulos G (1999) Development of viral vectors for gene therapy of beta-chain hemoglobinopathies: optimization of a gamma-globin gene expression cassette. Blood 93:2208-2216
26. Linardaki GD, Boki KA, Fertakis A, Tzioufas AG (1999) Pure red cell aplasia as presentation of systemic lupus erythematosus: antibodies to erythropoietin. Scand J Rheumatol 28:189-191
27. Lucarelli G, Galimberti M, Polchi P, Angelucci E, Baronciani D, Giardini C, Andreani M, Agostinelli F, Albertini F, Clift RA (1993) Marrow transplantation in patients with thalassemia responsive to iron chelation therapy. N Engl J Med 329:840-844
28. Lukens JN (1993) The thalassemias and related disorders: quantitative disorders of hemoglobin synthesis. In: Wintrobe's clinical hematology, 9th edn. Lea & Febiger, Philadelphia, pp 1102-1145
29. Olivieri NS, Freedman MH, Perrine SP, Dover GJ, Sheridan B, Essentine DL, Nagel RL (1992) Trial of recombinant human erythropoietin: three patients with thalassemia intermedia. Blood 80:3258-3260
30. Piomelli S (1995) Recent advances in the management of thalassemia. Curr Opin Hematol 2:159-163
31. Prabhakar SS, Muhlfelder T (1997) Antibodies to recombinant human erythropoietin causing pure red cell aplasia. Clin Nephrol 47:331-335
32. Rachmilewitz EA, Aker M, Perry D, Dover G (1995) Sustained increase in haemoglobin and RBC following long-term administration of recombinant human erythropoietin to patients with homozygous beta-thalassemia. Br J Haematol 90:341-345
33. Rachmilewitz EA, Aker M (1998) The role of recombinant human erythropoietin in the treatment of thalassemia. Ann N Y Acad Sci 850:129-138
34. Rachmilewitz EA, Goldfarb A, Dover G (1991) Administration of erythropoietin in patients with beta-thalassemia intermedia: a preliminary trial. Blood 78:1145-1147
35. Sasaki H, Bothner B, Dell A, Fukuda M (1987) Carbohydrate structure of erythropoietin expressed in Chinese hamster ovary cells by a human erythropoietin cDNA. J Biol Chem 262:12059-12076
36. Singer ST, Wu V, Mignacca R, Kuypers FA, Morel P, Vichinsky EP (2000) Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly Asian descent. Blood 96:3369-3373
37. Sipsas NV, Kokori SI, Ioannidis JP, Kyriaki D, Tzioufas AG, Kordossis T (1999) Circulating autoantibodies to erythropoietin are associated with human immunodeficiency virus type 1-related anemia. J Infect Dis 180:2044-2047
38. Stivelman JC (1989) Resistance to recombinant human erythropoietin therapy: a real clinical entity? Semin Nephrol 9 [Suppl 2]:8-11
39. Tzioufas AG, Kokori SI, Petrovas CI, Moutsopoulos HM (1997) Autoantibodies to human recombinant erythropoietin in patients with systemic lupus erythematosus: correlation with anemia. Arthritis Rheum 40:2212-2216
40. Urra JM, de la Torre M, Alcazar R, Peces R (1997) Rapid method for detection of anti-recombinant human erythropoietin antibodies as a new form of erythropoietin resistance. Clin Chem 43:848-849
41. Voulgari, PV, Hatzimichael EC, Tsiara S, Tzallas C, Drosos AA, Bourantas KL (2001) Investigation for the presence of anti-erythropoietin antibodies in patients with myelodysplastic syndromes. Eur J Haematol 66:31-36
42. Zumberg MS, Procter JL, Lottenberg R, Kitchens CS, Klein HG (2001) Autoantibody formation in the alloimmunized red blood recipient: clinical and laboratory implications. Arch Intern Med 161:285-290